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Background: We examined the prevalence and health
related quality of life (HRQoL) of depression and/or pain
in neurology outpatients.
Methods: Patients at outpatient clinics completed depression,
pain, and HRQoL scales. Group comparisons between those
with pain alone, depression alone, both conditions, and
neither condition were done.
Results: Overall, pain was present in 2/3 and depression in
1/3 of patients. Pain with depression was present in 25%;
75% of depressed patients had pain. These conditions had
significant negative impact on mental and physical health
status scores. The odds ratio (OR) for having pain was
significantly increased in women (OR 2.0), those with
depression (OR 2.4), and those with neuropathy/neuromus-
cular (OR 3.8) or pain syndromes (OR 4.8). The odds of
having depression were increased in those with pain (OR
2.4) and with cognitive (OR 4.8) or cerebrovascular (OR 3.3)
diagnoses. Neurologists were more likely to recognise and
treat pain than depression.
Conclusions: Depression and pain are common in newly
referred neurology outpatients and have substantial negative
effects on patients’ physical and mental health. Pain is more
likely than depression to be recognised and treated by
neurologists.
P
rior studies have documented the high prevalence of
depression and pain diagnoses in primary care clinics,
but corresponding data for neurology outpatients are
scarce.1–4 Patients referred to neurology clinics may be at high
risk of depression and pain because of the chronic nature of
many neurological conditions, pain associated with neuro-
muscular disease and headache, and simply by being selected
for referral for their condition. Depressive and painful
symptoms may often present simultaneously as depression
associated pain or as comorbid conditions and, if so, are less
likely to respond to treatment.5 6 Further, how often
neurologists recognise and treat depression and pain in their
outpatients is not well described. The aims of this study were
to: (a) estimate the prevalence of depression and pain in
patients newly referred to three neurology outpatient clinics;
(b) assess the impact of these conditions on patients’ health
status; (c) identify patient characteristics associated with the
presence of these conditions, and (d) assess the frequency of
recognition and treatment of depression and pain symptoms.
METHODS
We identified consecutive newly referred patients to three
hospital based general neurology outpatient clinics from
January 2001 to August 2001. Patients with no cognitive or
language barriers to communication were eligible. Patients
referred to specialty clinics (for example epilepsy, Alzheimer’s
and multiple sclerosis) were excluded. Research assistants
approached patients in the clinic, explained the study, and
obtained informed consent. This study was approved by the
local institutional review board.
Study patients completed a series of questionnaires in the
clinic and at 3 and 12 month follow up; only baseline data are
included in this report. Pain was measured with the Brief
Pain Inventory (BPI).7 We used the Patient Health
Questionnaire nine item depression module (PHQ-9) to
assess depression symptoms.8 9 Scores >10 on the PHQ-9
represent clinically significant depression.9 Neurologists were
blinded to the PHQ-9 and BPI scores unless the patient
endorsed thoughts of death as a depression symptom. We
used the Medical Outcomes Study Short Form 12 (MOS SF-
12) to measure health status.10 This scale provides composite
measures of physical component summary (PCS) and mental
component summary (MCS) health status. Normative United
States population scores have been developed so that the
median PCS and MCS score is 50 and lower scores indicate
worse health status.
After the clinic visit, standardised clinic encounter forms
and physicians’ dictated notes were reviewed to determine
the primary neurological diagnosis and physician recognition
and treatment of pain and mental health diagnoses. Research
assistants used an intentionally liberal standardised list of
words, phrases, and treatments (for example continuing a
treatment or referring for treatment by another provider) to
assess physician recognition and treatment of depression and
pain.
Patients were categorised into four groups: depression
alone, pain alone, pain with depression, and neither. One
way ANOVAs were conducted to test for mean differences of
the SF-PCS and SF-MCS by depression and pain groups using
the Tukey-Kramer method to adjust for pair wise compar-
isons. We also modelled depression and pain separately using
logistic regression, with sex, age, clinic site, and diagnoses as
covariates. x2 Tests and odds ratios (ORs) were used to test
the significance of independent variables. Possible interac-
tions between independent variables were also evaluated in
both models.
RESULTS
Of the 587 patients newly referred during the six months of
enrollment, 483 (82%) were enrolled in the study, 92 (16%)
refused participation, and 12 (2%) were ineligible. Sample
characteristics are shown in table 1.
The most common primary diagnoses at the close of the
baseline visit (fig 1) were neuropathy or neuromuscular
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disease (n = 109) and headache (n = 101). The symptomatic
diagnosis category (n = 61) included diagnoses codes such as
dizziness and numbness. It is striking that pain (alone or
with depression) is reported in at least 40% of all subjects
regardless of diagnosis group.
The table also summarises baseline health status scores for
patients with depression, pain, both depression and pain, or
neither. Nearly two thirds of patients reported pain, one third
screened positive for depression, and one fourth had both
depression and pain. Of those with pain, 33% were also
depressed. Of those with depression, 75% also had pain.
Using the PHQ-9 diagnostic algorithm, 50% of those with
depression (17% of the total sample) had major depression
and 22% (13% of the total sample) had ‘‘other depression’’.
The depression alone group was almost twice as likely to
consist of men (62% men v 38% women), while the pain with
depression group was almost twice as likely to consist of
women (61% women v 39% men, p,0.01).
Patient health status was significantly affected by pain and
depression. SF-12 PCS and MCS scores approached the norm
national median score of 50 only in those without pain or
depression. PHQ-9 scores were also higher in those with
comorbid pain and depression than in those with depression
alone. Further, pain intensity and pain interference scores
were significantly higher in the group with pain and
depression than in those with pain alone.
In logistic regression models, the odds of having pain were
significantly increased in women (OR 2.0, 95% CI 1.2 to 3.2),
in those with depression (OR 2.4, 95% CI 1.4 to 4.0), and in
those with neuropathy/neuromuscular (OR 3.8, 95% CI 1.5 to
9.7) or pain syndrome (OR 4.8, 95% CI 1.4 to 16.5) diagnoses.
The odds of having depression were significantly increased in
those with pain (OR 2.4, 95% CI 1.5 to 3.9) and in those with
cognitive (OR 4.8, 95% CI 1.3 to 18.0) or cerebrovascular (OR
3.3, 95% CI 1.0 to 10.6) diagnoses.
Neurologists were more likely to recognise and treat pain
than depression, but the presence of pain and depression
together did not significantly affect recognition and treat-
ment rates. Pain was recognised in 77% with pain and
depression and 72% of those with pain alone (p = NS), while
depression was recognised in 48% of the pain with depression
group and in 40% of those with depression alone (p = NS).
Similarly, patients with depression and pain were no more
likely than those with either condition alone to receive a
treatment plan. Overall, only 41% of patients screening
positive for depression and 50% with major depression
received psychological treatment.
DISCUSSION
There is a high prevalence of depression and pain in patients
referred to neurology outpatient clinics, with significant pain
reported by more than two thirds of patients and depression
present in one third. Although the prevalence varies some-
what by neurological diagnosis, no specific category of
neurological disease is especially free of these conditions.
Importantly, pain with depression is particularly common,
being present in one in four newly referred outpatients in our
sample. It is also clear that these conditions have a
substantial adverse impact on patients’ physical and mental
health, with mean health status scores below the national
median in all groups except those with neither pain nor
depression. Despite differences in the process of neurology
referral in the United States and the United Kingdom, these
results are similar to a recent British study conducted by
Carson and colleagues.1
Our study also demonstrates the strong relationship
between depression and pain. This highlights the importance
of recognising both conditions, because patients’ health
status and the perception of pain are significantly worse
when both depression and pain are present. Moreover, this
comorbidity has important implications for patient manage-
ment, because other studies have documented greater
difficulty in treating pain when depression is coexistant.5 6
The cross sectional nature of these data limits the ability to
disentangle this complex relationship, but follow up data in
this cohort are being accrued that may help to address this
important issue.
Neurologists were more likely to recognise and treat pain
than depression, but the presence of pain with depression did
Table 1 Patient demographic and health status scores
Depression




(n = 122) Neither (n = 124) p Value*
Age 51.1 (SD 21) 48.9 (SD 16) 48.2 (SD 15.3) 52 (SD 18) 0.28
Percentage female 38 56 61 43 0.008
Percentage Caucasian 90 88 84 88 0.68
PCS score 42.5 (SD 10.5) 36.1 (SD 10.7) 31.3 (SD 8.9) 46.8 (SD 10.1) ,0.001
MCS score` 37.8 (SD 10.6) 50.3 (SD 9.5) 34.2 (SD 12.3) 51.6 (SD 8.9) ,0.001
Pain intensity – 4.5 (SD 2.0) 6.1 (SD 2.1) – ,0.001
Pain interference – 4.5 (SD 2.3) 7.1 (2.1) – ,0.001
PHQ-9 13.2 (SD 4.1) 4.5 (SD 2.9) 16.0 (SD 5.0) 3.3 (SD 2.9) ,0.001
*p Values are for overall tests (x2 tests are used for percentage female and percentage white).
All pair wise comparisons significant at p ,0.003 except for ‘‘depression alone’’ group versus ‘‘neither’’ group.
`All pair wise comparisons significant at p ,0.001 except for ‘‘pain with depression’’ group versus ‘‘depression
alone’’ group and ‘‘pain alone’’ group versus ‘‘neither’’ group.
Pair wise comparisons adjusted by Tukey-Kramer method.
MCS, mental component summary; PCS, physical component summary; PHQ-9, Patient Health Questionnaire, nine
item.
Figure 1 Depression and pain screening by primary diagnosis.
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not significantly increase recognition and treatment. This is
not surprising because it is well established that most
patients with depression in primary care present with somatic
rather than emotional complaints,11 12 and because prior studies
suggest that depression is less likely to be recognised and
treated when physical comorbidities compete with depression
symptoms during an outpatient visit.13 Because neurologists
were not directly asked after each visit about their impression of
either pain or depression, their assessment of these conditions
may have been underestimated. Alternatively, because an
intentionally liberal review of the written documentation of
depression was employed, the recognition of depression may
have been overestimated.
This study also documents a higher screening prevalence of
depression in neurology clinics compared with primary care,
where approximately 13–17% of patients screen positive for
depression.8 9 14–16 This higher prevalence has also been
demonstrated in other specialty settings, including gastro-
enterology17 and rheumatology,18 and may indicate the need
for increased training of specialists to recognise depression
and for implementation of standardised screening pro-
grammes in settings where depression prevalence is high.
Although we attempted to reduce the potential for selection
bias by avoiding recruitment in identified specialty clinics,
this may have made this cohort less generalisable to the
private practitioner and reduced the assessment of common
important conditions like epilepsy, a condition in which
depression has been reported to be prevalent.19
Even if one argues that a neurologist (or any specialty
consultant) is not the appropriate healthcare provider to treat
depression in a given patient, recognising depression is
important because it may affect treatment the neurologist
prescribes. Further, neurologist recognition of depression
may assist patients and their primary healthcare providers in
obtaining optimal treatment for this debilitating disorder.
Thus, neurologists might consider implementing simple,
valid screening tests for depression in their newly referred
patients, especially those with significant pain.20 Future
studies should examine the longer term impact of these
conditions on patient health status and satisfaction, the
impact of depression on treatment for pain and other
neurological symptoms, and the association between physi-
cian recognition and treatment of pain and depression and
subsequent patient outcomes.
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